Inflammasome complexes function as key innate immune effectors that trigger inflammation in response to pathogen-and danger-associated signals. Here, we report that germline mutations in the inflammasome sensor NLRP1 cause two overlapping skin disorders: multiple self-healing palmoplantar carcinoma (MSPC) and familial keratosis lichenoides chronica (FKLC). We find that NLRP1 is the most prominent inflammasome sensor in human skin, and all pathogenic NLRP1 mutations are gain-of-function alleles that predispose to inflammasome activation. Mechanistically, NLRP1 mutations lead to increased self-oligomerization by disrupting the PYD and LRR domains, which are essential in maintaining NLRP1 as an inactive monomer. Primary keratinocytes from patients experience spontaneous inflammasome activation and paracrine IL-1 signaling, which is sufficient to cause skin inflammation and epidermal hyperplasia. Our findings establish a group of non-fever inflammasome disorders, uncover an unexpected auto-inhibitory function for the pyrin domain, and provide the first genetic evidence linking NLRP1 to skin inflammatory syndromes and skin cancer predisposition.
SUMMARY
Inflammasome complexes function as key innate immune effectors that trigger inflammation in response to pathogen-and danger-associated signals. Here, we report that germline mutations in the inflammasome sensor NLRP1 cause two overlapping skin disorders: multiple self-healing palmoplantar carcinoma (MSPC) and familial keratosis lichenoides chronica (FKLC). We find that NLRP1 is the most prominent inflammasome sensor in human skin, and all pathogenic NLRP1 mutations are gain-of-function alleles that predispose to inflammasome activation. Mechanistically, NLRP1 mutations lead to increased self-oligomerization by disrupting the PYD and LRR domains, which are essential in maintaining NLRP1 as an inactive monomer. Primary keratinocytes from patients experience spontaneous inflammasome activation and paracrine IL-1 signaling, which is sufficient to cause skin inflammation and epidermal
INTRODUCTION
The timely activation and resolution of the innate immune response is essential for host defense, tissue homeostasis, and tumor immunosurveillance. One key innate immune pathway relies on the inflammasome complexes, which consist of an array of ligand-sensing nucleotide-binding domain, leucine-rich repeat containing (NLR) proteins, the adaptor protein ASC, and caspase-1. NLR proteins patrol the cytosol and initiate inflammasome assembly, pyroptotic cell death, and pro-inflammatory cytokine release upon ligand binding (Broderick et al., 2015; Davis et al., 2011; Latz et al., 2013) . While the inflammasome complexes are essential for pathogen clearance under physiological conditions, their aberrant activation can be detrimental. This is evident in a group of auto-inflammatory disorders caused by germline-activating mutations in inflammasome sensor proteins (Kastner et al., 2010; Masters et al., 2009) , including cryopyrin-associated periodic syndromes (CAPSs) (Hoffman et al., 2001) , familial Mediterranean fever syndromes (FMFs) (The International FMF Consortium, 1997) , and certain forms of macrophage activation syndrome (MASs) (Canna et al., 2014; Kitamura et al., 2014; Romberg et al., 2014) . These patients experience diagnostic symptoms such as periodic fever and sterile inflammation as a result of spontaneous macrophage activation and release of pyrogenic cytokines.
Although the function of NLR proteins in systemic inflammation is well established, less is known about their roles in organ-specific immune response and tissue homeostasis, particularly in epithelial tissues such as the skin. Apart from forming a structural barrier, human skin actively interacts with the immune system in guarding against invading pathogens and tissue damage. On the other hand, chronic unresolved skin inflammation can result in a variety of dermatological diseases and promote the development of both benign and malignant epithelial skin lesions (Elinav et al., 2013; Grivennikov et al., 2010) . Recent work suggests that certain inflammasome complexes are involved in skin inflammation, but the exact mechanisms remain incompletely understood (Feldmeyer et al., 2007; Sollberger et al., 2015) .
In this study, we describe two overlapping Mendelian monogenic skin disorders: multiple self-healing palmoplantar carcinoma (MSPC; OMIM: 616964) and familial keratosis lichenoides chronica (FKLC). These two skin diseases are allelic and caused by distinct gain-of-function mutations in the inflammasome sensor protein, NLR family, pyrin domain containing protein 1 (NLRP1). We report that NLRP1 is the most prominently expressed inflammasome sensor in human skin. Through functional analyses of the disease-causing mutations, we discover an unexpected mechanism of activation for NLRP1 that differs from other inflammasome sensors: wildtype NLRP1 is kept as an inactive monomer by the combined action of the PYD (pyrin domain) and LRR domain. MSPC and FKLC mutations disrupt these two domains, respectively, leading to constitutive NLRP1 self-oligomerization and inflammasome activation. We furthermore provide evidence for spontaneous inflammasome activation and IL-1 secretion in patients' keratinocytes. Using ex vivo organotypic skin models, we demonstrate that inflammasome-dependent IL-1 cytokines can directly cause skin hyperplasia. These findings expand the clinical diversity of inflammasome disorders to non-fever skin diseases. To the best of our knowledge, our results also provide the first genetic evidence connecting inflammasome signaling to inflammatory skin disorders and skin cancer predisposition.
RESULTS

Pedigrees and Clinical Features of MSPC and FKLC
We previously described a Tunisian kindred ( Figure 1A , MSPC-TN-1) that presented with an autosomal dominant skin order, MSPC (OMIM: 616964) (Mamaï et al., 2015) . Affected patients developed numerous ulcerative, hyperkeratotic nodular growths on plantar and palmar skin. Clinically, these lesions resemble rapidly growing benign proliferative epithelial skin lesions known as keratoacanthomas (KAs) but display histologic features of well-differentiated squamous cell carcinomas (SCCs) ( Figures  1B-1D ). These lesions mostly regressed spontaneously after $6 months (Mamaï et al., 2015) . However, MSPC patients experienced increased susceptibility to malignant SCC ( Figure 1E ; Table S1 ). In addition, 12 out of 15 patients (80%) developed conjunctival lesions characterized histologically by squamous dyskeratotic lobules ( Figure 1H ). The putative MSPC locus in this kindred was found to map to chromosome 17p (Mamaï et al., 2015) , suggesting a distinct genetic etiology from a similar proliferative skin disease, multiple self-healing squamous epithelioma (MSSE; OMIM: 132800) caused by mutations in TGFBR1 (Goudie et al., 2011) .
Based on these symptoms, we ascertained two additional MSPC kindreds ( Figures 1A, 1F , 1G, S1C, and S1D), including one family that was originally diagnosed with corneal intraepithelial dyskeratosis (MSPC-FR-1) (Soler et al., 2013) (Figure 1I) . In addition to characteristic palmoplantar KAs, a subset of MSPC patients displayed irregular and thickened nails (Figure S1G) and hyperkeratosis pilaris (Figures S1H, S1K, S1J; Table S1 ).
While this manuscript was under revision, we discovered a fourth family that shared several clinical features with MSPC (FKLC-EG-1) ( Figures 1A, 1L , S1L, S1M, S1Q, and S1R). In addition, the affected children presented with multiple discrete and semi-confluent lichenoid papules on the arms, legs, and lower trunks ( Figures 1J, 1K , S1N, and S1O). Based on these symptoms, the two affected siblings were diagnosed with FKLC. Keratosis lichenoides chronica (KLC), also known as Nekam's disease, is a mostly sporadic chronic skin inflammatory condition with no defined genetic etiology. Further clinical examination revealed that both parents also displayed noticeable, albeit less severe skin phenotypes including plantar keratosis, follicular hyperkeratosis (Figures S1L and S1M) and macular amyloidosis (Table S1 ), suggesting that the skin pathology in this kindred is caused by a semi-dominant allele.
To ascertain the causal mutation(s) in MSPC and FKLC, we performed whole-exome sequencing on genomic DNA isolated from MSPC1-TN-1 IV:13 and FKLC-EG-1 V:3 and V:5. After removing annotated polymorphisms, a single heterozygous (B-L) exonic variant (Chr. 17: 5, 487, 118 G>A, hg19) in exon 1 of the NLRP1 gene was identified within the candidate genomic locus (Chr. 17: 1, 541, 964, 181) . Further Sanger sequencing confirmed that this mutation segregated with disease among 16 other MSPC-TN-1 family members ( Figure 1A, top) . The resulting amino acid change A54T (Figures 2A and 2B ) affects a highly conserved residue and is predicted to be deleterious by PolyPhen2 and SIFT algorithms. Remarkably, this missense mutation is found near another missense mutation, M77T that was previously identified in MSPC-FR-1 (Soler et al., 2013) (Figures  2A and 2B ). One member of MSPC-TN-1, III:5 was reported to be asymptomatic despite being a carrier of the A54T mutation, suggesting the existence of possible modifier alleles. Sanger sequencing of NLRP1 exon 1 from the MSPC-RO-1 index patient III:3 revealed a third heterozygous mutation, A66V (Figures 2A  and 2B; Table S2 ), which segregates with disease in additional family members ( Figure 1A ). No mutations were found in the TGFBR1 coding sequence in MSPC-RO-1 or other MSPC families (Table S3) .
Whole-exome sequencing of FKLC-EG-1 V:3 and V:5 revealed that both affected children harbored a homozygous deletion within the NLRP1 locus that removed the fifth exon (Figures 2A  and S2A ). Subsequent Sanger sequencing revealed that this deletion was present in the heterozygous state in both parents ( Figure S2B , left) and absent in unaffected siblings. The truncated, exon-5-deleted transcript was readily detectable in total mRNAs isolated from the proband V:3 ( Figure S2B , right). At the protein level, this leads to an internal in-frame deletion p.F787_R843del, which removes the first of the six leucine-rich repeats (LRR) and part of the preceding linker region (Figures 2A and S2A) . Taken together, these findings suggest that MSPC and FKLC are allelic disorders that are caused by distinct germline mutations in the same gene-NLRP1. The severe symptoms of the two affected children in FLKC-EG-1 are most likely due to the homozygous inheritance of a semi-dominant NLRP1 mutant allele, which manifests as milder skin defects in the heterozygous parents.
NLRP1 Is the Predominant Inflammasome Sensor in Human Skin
The physiological function of NLRP1 remains less understood than that of other inflammasome sensors such as NLRP3. Genome-wide association studies have implicated NLRP1 haplotypes in psoriasis and vitiligo-related autoimmune diseases (OMIM: 606579), suggesting that NLRP1 might play a role in skin-specific immune response (Jin et al., 2007; Levandowski et al., 2013) . To explore the potential functions of NLRP1 in the skin, we first examined its tissue expression profile in the Human Protein Atlas RNA-seq database (Uhlé n et al., 2015) . We found that NLRP1 is widely expressed, in contrast to other NLRs such as NLRP3, AIM2, NLRC4, and MEFV, which have more restricted tissue distributions ( Figures 2C, S2C , and S2D). Remarkably, the skin was found to have the highest expression level of NLRP1 of all human tissues tested (FKPM [fragments per kilobase of exon per million fragments mapped] = 58.2 ± 17.4), whereas other known inflammasome sensors including NLRP3, AIM2, NLRC4, and MEFV were not expressed in skin (FKPM < 1) ( Figures 2C, S2C , and S2D).
We next examined the transcript levels of NLRP1 and other inflammasome components in the three major cell types in the skin, namely, keratinocytes, melanocytes, and fibroblasts. NLRP1 was readily detectable by RT-PCR in keratinocytes and fibroblasts, but not in melanocytes. In contrast, none of the other known inflammasome NLRs could be detected in the skin cell types ( Figure 2D, left) . Keratinocytes, but not fibroblasts, express all other inflammasome components, including CASP1, ASC (also known as PYCARD), right, lane 3, and S2E) . In fact, the levels of IL-1B and IL-18 in cultured primary keratinocytes exceed those in unstimulated peripheral blood mononuclear cells (PBMCs) (Figures 2D and S2F ), suggesting that keratinocytes are poised to initiate inflammasome signaling without prior priming.
We next verified the expression of NLRP1 in paraffin preserved primary human skin samples. Using RNAscope in situ staining, we found that NLRP1 mRNA is expressed throughout the epidermis and in dermal fibroblasts in both glabrous skin and plantar skin (Figures 2E, top, and S2G) , in agreement with the RT-PCR results. This was corroborated by immunohistochemical staining using an anti-NLRP1 antibody ( Figure 2E , middle and bottom). In addition, NLRP1 is expressed in epidermal appendages such as hair follicles ( Figure S2H ), consistent with the follicular hyperkeratosis seen in MSPC and FKLC patients (Figures S1H, S1J, S1K, S1M, and S1O; Table S1 ).
MSPC and FKLC Mutations Cause Increased Inflammasome Activation
Many inflammasome-activating NLR proteins share a common domain structure that comprises of an N-terminal PYD followed by a NACHT and LRR domain. In general, NLR PYDs are thought to initiate inflammasome assembly, whereas the NACHT and LRR domains regulate self-association and/or ligand binding. Among all PYD-containing NLRs, human NLRP1 uniquely possesses a C-terminal CARD (caspase activation and recruitment domain) preceded by an auto-proteolytic FIIND (''function-tofind'' domain) (Figure 2A ), both of which contribute to inflammasome activation (D'Osualdo et al., 2011; Finger et al., 2012) .
All of the three germline missense mutations in MSPC, A54T, A66V, and M77T are found within the N-terminal PYD ( Figures  2A and 2B ). Remarkably, this domain is absent in NLRP1 homologs in non-primate mammalian species, with the possible exception of dogs and horses. Murine genomes contain three NLRP1 homologs, Nlrp1a, b, and c, but none encodes a PYD ( Figure S2A, top) . In contrast, the amino acid residues (F787-R843) deleted in FKLC-EG-1 are conserved between men and rodents and encompass the first LRR in the LRR domain as well as part of the preceding linker region ( Figure S2A ). The NLRP1 LRR domain likely participates in auto-inhibition, as an NLRP1 DLRR mutant has been shown to cause constitutive inflammasome activation in vitro (Martinon et al., 2002) . Similarly, the linker region has been implicated in the auto-inhibition of murine Nlrp1a (Masters et al., 2012) , although its role in human NLRP1 is unclear.
To expressing ASC-GFP (293T-ASC-GFP) were transfected with plasmids encoding NLRP1 MSPC and FKLC mutants, we observed a significant increase in the percentage of cells with ASC-GFP specks relative to those expressing wild-type NLRP1 ( Figure 3A ). In addition, a higher amount of ASC dimers and oligomers were observed in cells that overexpressed NLRP1 mutants after DSS crosslinking ( Figure 3B , lanes 3,4,5, and 8 versus lane 2). These in vitro results suggest that NLRP1 mutants in MSPC and FKLC can cause increased inflammasome assembly as compared to wild-type NLRP1. Due to the high degree of natural polymorphisms in NLRP1, we cloned all minor alleles of NLRP1 with non-synonymous SNPs in the PYD. None of the 16 SNPs significantly altered the percentage of 293T-ASC-GFP cells with specks ( Figure 3C ), supporting the notion that the NLRP1 variants found in MSPC patients are true, rare, pathogenic mutants.
Next, we examined whether NLRP1 mutants in MSPC could lead to increased processing of pro-IL-1b by caspase-1. To this end, wild-type NLRP1, NLRP1 mutants, pro-caspase-1, and pro-IL-1b were overexpressed in HEK293T ASC-GFP cells to reconstitute a functional inflammasome complex. All three MSPC and FKLC mutants led to higher amount of pro-IL-1b cleavage than wild-type NLRP1 ( Figure 3D , lanes 3, 4, and 5 versus lane 2; lane 11 versus lane 10) at a level that was comparable to a known gain-of-function NLRP3 R262W mutant (Figure 3D , lane 7 versus lane 6). Together, these results demonstrate that all NLRP1 mutants cause hyper-activation of the inflammasome in vitro. Furthermore, we found that all four disease-associated NLRP1 mutants caused significant amounts of mature IL-1b secretion when expressed at physiological levels in immortalized keratinocytes ( Figure 3E , lanes 4-7 versus lane 3). This effect was found to depend on the adaptor protein ASC, as keratinocytes pre-treated with siRNAs against ASC showed a significant decrease in the level of secreted IL-1b following mutant NLRP1 overexpression ( Figure 3F , inset, lane 2 versus lanes 1 and 3).
Although the gain-of-function effect of the FKLC mutant, F787_R843del can be readily rationalized by the auto-inhibitory function of the LRR domain, it is surprising that mutations in the PYD, which is widely thought to promote ASC assembly, can lead to a similar effect. To obtain additional evidence to confirm the gain-of-function effects of MSPC NLRP1 mutants, we generated stable THP-1 cell lines that expressed doxycycline-inducible wild-type and mutant NLRP1 (A54T, M77T, or A66V) (Figures S3A and S3B) . THP-1 macrophages expressing NLRP1 mutants experienced increased cell death and secretion of mature IL-1b ( Figures S3C and S3D ), which could be blocked by caspase-1 inhibitor, Z-WEHD-FMK ( Figure S3E ), or CRISPR/Cas9-mediated deletion of ASC (PYCARD) or caspase-1 (CASP1) ( Figure S3F ). Together, these results further demonstrate that the NLRP1 MSPC mutations suffice to cause increased inflammasome activation.
The Pyrin Domain of NLRP1 Functions as an Atypical, Auto-inhibitory Domain As compared to other inflammasome sensor proteins, NLRP1 uniquely consists of both a PYD and CARD ( Figure 2A ). Sequence comparison of all PYDs encoded in the human genome revealed that NLRP1 PYD defines its own branch (Figure 4A) . However, all the amino acid residues that are mutated in MSPC, namely A54, A66, and M77 are conserved in other NLRs, including known inflammasome sensors NLRP3, AIM2, and MEFV ( Figure 4B ).
To further characterize how A54T, A66V, and M77T lead to inflammasome hyperactivation, we first tested the possibility that these mutations directly enhance ASC oligomer assembly. While both NLRP3 PYD and AIM2 PYD domain led to robust ASC speck formation when expressed as mCherry-fusion proteins in 293T ASC-GFP cells ( Figure 4C ), neither wild-type NLRP1 PYD, nor the mutant PYDs caused ASC specks in the same setting ( Figures 4C and S4A ). Hence NLRP1 PYD is unlikely to directly enhance ASC speck formation.
Based on these results, we infer that NLRP1 PYD might play a fundamentally different role from other PYDs. It might maintain NLRP1 in an auto-inhibited, inactive state, instead of directly engaging in ASC oligomer formation. To test this hypothesis, we assayed the ability of a series of N-terminally truncated NLRP1 mutants to initiate ASC-speck formation in 293T ASC-GFP cells (Figures 4D, 4E, and S4B) . Similar to the MSPC mutant M77T, all N-terminal truncation mutants showed an $3-to 6-fold increase in the percentage of cells with ASC-GFP specks (Figures 4D and 4E) and led to increased IL-1b processing ( Figure S4D , lanes 3-9 versus lane 2). Notably, simply removing the PYD (aa 93-1474; Figure 4D ) caused increased ASC-GFP speck formation and increased IL-1b processing, despite very low expression levels of this mutant ( Figure S4D , lane 4). In addition, all NLRP1 truncation mutants lacking the PYD led to increased secretion of endogenous IL-1b in immortalized keratinocytes ( Figure 4F ). In fact, the C-terminal auto-proteolytic fragment, (aa 1213-1474) was sufficient to nucleate ASC-GFP specks ( Figure 4G ) and strongly activate inflammasome signaling ( Figures 4D-4F ).
Conversely, all C-terminal truncation mutants lacking the CARD failed to increase the number of ASC specks in 293T ASC-GFP cells ( Figure 4F and S4C), increase IL-1b processing ( Figure S4D , lanes 10 and 11 versus lanes 2 and 3, and S4E, lanes 8-11 versus lane 7), or activate IL-1b secretion in immortalized human keratinocytes, even in the presence of the M77T mutation ( Figure 4F ). Taken together, these results demonstrate that NLRP1 PYD is an auto-inhibitory domain, while the C-terminal auto-proteolytic fragment encompassing the CARD is responsible for activating the inflammasome.
NLRP1 Mutations in MSPC Disrupt PYD Domain Folding
Our functional characterization of NLRP1 PYD suggests that the three missense MSPC mutations likely cause inflammasome hyper-activation by disrupting PYD-dependent auto-inhibition. Previously we have shown that NLRP1 PYD forms a bundle of five a helices (Hiller et al., 2003) , in contrast to the canonical death domain superfamily fold consisting of six helices (Figure 4H) . Interestingly, MSPC mutations A54T, A66V, and M77T all affect residues that are located along the central helices (a4 and a5) within the hydrophobic core ( Figure 4H ). Mutations of these residues are thus expected to destabilize the PYD structure. To test this, we purified recombinant wild-type and mutant NLRP1 PYDs. With the exception of M77T, all recombinant PYDs were soluble and isolated to >99% purity ( Figure S4F , inset) and eluted as a single monomer from size-exclusion chromatography ( Figure S4F ). We then queried the folding state of all recombinant NLRP1 PYDs using in-solution 2D [ 15 N, 1 H]-HSQC NMR. Remarkably, while wild-type NLRP1 PYD and the three PYD SNP variants S55L, E63K, and Q64L displayed welldispersed chemical shift spectra that are characteristic of natively folded proteins (Figures 4I, left, and S4G) , both MSPC mutants, A54T and A66V, were found to populate the ''random coil'' region ( Figure 4I , middle and right), indicating that the A54T and A66V mutants are misfolded/unfolded in solution. These findings were corroborated by circular dichroism analysis of recombinant wild-type and mutant NLRP1 PYDs ( Figure S4H ). As further evidence for the requirement of these conserved residues to maintain the overall PYD architecture, we found that ''transplanting'' the MSPC mutations to NLRP3 ( Figure 4H ) abrogates PYD-dependent inflammasome activation ( Figures S4I  and S4J ).
Mechanistic Basis for NLRP1 PYD-and LRR-Mediated Auto-inhibition Elucidating the structural basis for NLRP1 activation has been traditionally hampered by a lack of a bona fide ligand for NLRP1. We reasoned that the activating mutants identified from MSPC and FKLC kindreds might offer a unique opportunity to probe the mechanistic basis for NLRP1 inflammasome activation.
To address this question, we used blue native PAGE (BN-PAGE) to directly visualize the native conformations of wildtype and patient-derived mutant NLRP1 proteins. Overexpressed wild-type NLRP1 migrated as a prominent band at a molecular size of $150 kDa under native conditions ( Figure 5A , top and middle), which is similar in size to native rabbit IgG ( Figure S5A ) and denatured uncleaved NLRP1 on SDS-PAGE ( Figure 5A , bottom). Hence the majority of wild-type NLRP1 molecules are likely monomeric. In contrast, the abundance of this 150 kDa, monomeric species was drastically reduced for the MSPC and FKLC mutants. Instead, these mutants predominantly migrated as high molecular weight oligomers ( Figure 5A , lanes 2-5). These results suggest that the PYD and LRR domain are independently required to maintain NLRP1 as a monomer and prevent spontaneous self-oligomerization. Consistent with this model, the DPYD mutant (aa 93-1474) was found exclusively as a high molecular weight oligomer (Figure other hand, exists exclusively as oligomers of $1000 kDa (Figure 5B , lane 5). Together with our previous functional experiments ( Figures 4A-4F ), we surmised that this fragment contains all the critical structural elements required for NLRP1 oligomerization and inflammasome activation. If this were true, blocking the generation of this fragment via auto-proteolytic cleavage should inhibit inflammasome activation by NLRP1 mutants. Indeed, when the cleavage site mutation F1212A was introduced into MSPC and FKLC mutants ( Figure 5C , bottom), it severely diminished NLRP1 oligomerization and caused the re-appearance of the monomeric, 150 kDa band ( Figure 5C , lanes 4, 6, and 8 versus lanes 3, 5, and 7). Functionally, the F1212A mutation abrogated the ability of the MSPC and FKLC mutants to nucleate ASC-GFP specks in 293T cells ( Figure 5D ) and to activate caspase-1-dependent IL-1b secretion in keratinocytes (Figure 5E ), confirming that auto-proteolytic cleavage is a pre-requisite for NLRP1 oligomerization and downstream inflammasome activation.
We further characterized the role of the C-terminal cleavage fragment in NLRP1 MSPC mutants using 2D-PAGE. NLRP1-expressing 293T lysates were fractionated by BN-PAGE, eluted from excised gel slices, and further separated by reducing SDS-PAGE. Full-length wild-type NLRP1 and its C-terminal fragment were both predominantly found in a lower molecular weight fraction corresponding to $150 kDa, similarly to native, tetrameric GAPDH ( Figure S5B , fraction 5, bottom). In contrast, NLRP1 M77T mutants displayed increased levels of the C-terminal fragment in high-molecular weight fractions ( Figure S5B , middle, fractions 1-4), suggesting that the increased oligomerization of the NLRP1 mutants can indeed be attributed to the C-terminal auto-proteolytic fragment.
Taken together, these findings lead us to propose the following model for NLRP1 function ( Figure 5F ). While wildtype NLRP1 exists as an inactive monomer in the absence of a ligand, binding to a putative ligand rapidly causes NLRP1 to self-oligomerize in a manner that is dependent on auto-proteolytic cleavage within the FIIND domain. When the PYD or the LRR domain is mutated as in MSPC and FKLC respectively, this self-inhibitory mechanism is lost. This triggers constitutive self-oligomerization and spontaneous inflammasome activation. In addition, unlike other NLR PYDs, recombinant NLRP1 PYD does not initiate ASC filament formation in vitro ( Figure S5C ), and we did not detect a direct interaction between NLRP1 PYD and CARD ( Figure S5D ).
NLRP1 Activation Causes Epidermal Inflammation and
Hyperplasia via Paracrine IL-1 Signaling As primary human epidermal keratinocytes are the major skin cell type expressing all components of the NLRP1 inflammasome (Figure 2 ), NLRP1 activation within keratinocytes is likely to contribute directly to MSPC and FKLC pathology. NLRP1 overexpression in immortalized keratinocytes (Figures 6A and S6B) led to peri-nuclear ASC specks exclusively in cells expressing NLRP1 mutants ( Figure S6A ) and a >100-fold increase in the levels of inflammasome-dependent cytokines, IL-1a, IL-1b, and IL-18 released into the culture media ( Figure 6B ). Co-incubation with a specific caspase 1 inhibitor, Z-WEVD-FMK abrogated this increase ( Figure 6B ). In addition, keratinocytes expressing NLRP1 mutants demonstrated >5-fold increase in cell death relative to wild-type NLRP1, as measured by lactate dehydrogenase release ( Figure S6C ).
We next used next-generation RNA sequencing to characterize the consequences of MSPC NLRP1 mutants on keratinocyte gene expression ( Figure 6C ). Unsupervised clustering of differentially regulated transcripts clearly distinguished the mutant NLRP1 expressing keratinocytes from the controls, despite a very modest level of overexpression (1.2-fold by FKPM; Figure S6D ). Gene set enrichment analysis (GSEA) revealed a remarkable enrichment of IL-1/NFkB signaling pathway genes among the upregulated transcripts ( Figure 6C, right) , suggesting that IL-1/NFkB activation might be a likely driver for the skin pathology seen in MSPC and FKLC.
A closer examination of the upregulated transcripts revealed a significant overlap with a previously published dataset on recombinant IL-1a-inducible genes in primary keratinocytes (Figure 6D , inset) (Yano et al., 2008) . These include stress-responsive secreted factors, known pro-inflammatory cytokines, as well as keratinocyte differentiation markers ( Figures 6D, S6E , and S6F). These results suggest that the consequences of NLRP1 inflammasome activation extend well beyond the immediate pyroptotic cell death and IL-1 release from the initiating cells. The secreted IL-1 cytokines likely trigger the release of other inflammatory cytokines from surrounding cells, creating a paracrine, pro-inflammatory milieu. Consistent with this model, treatment with recombinant IL-1 and TNFa, as well as conditioned media from a MSPC primary keratinocyte culture led to increased transcript levels of keratinocyte stress markers S100A9 and PI3 ( Figure S6G ) as well as IL-6, IL-8, and FGF7 (also known as keratinocyte growth factor, KGF) from dermal fibroblasts ( Figure S6H ). Given that these cytokines and growth factors have well-documented roles in skin inflammatory and proliferative diseases (Maas-Szabowski et al., 2000) , we further surmised that the recurrent, focal hyperkeratotic growth seen in both MSPC and FKLC patients is a direct result of IL-1-driven pro-inflammatory and pro-proliferative paracrine signaling. Indeed, skin organotypic cultures treated with IL-1a, IL-1b, and IL-18 showed a significant increase in epidermal thickness (Figures 6E and 6F, left) and proliferative, Ki67-positive cells in the basal layer ( Figure 6E and 6F, right) and an expansion of suprabasal, keratin-10, and involucrin-positive differentiated keratinocytes ( Figure 6E ). This was consistent with the upregulation of keratinocyte differentiation markers in our RNA-seq experiment ( Figures 6D and S6E ) and the highly keratinized nature of the MSPC and FKLC lesions ( Figures 1B-1D, 1F, 1L , and S1F). Furthermore, IL-1-treated ex vivo epidermis significantly upregulated stress-markers S100A8/9 and S100A7/psoriasin (Figure S6I) . These data provide further evidence that paracrine IL-1/NFkB signaling is sufficient to cause epidermal hyperplasia. F787_R843del/F787_R843del lesional, and NLRP1 NLRP1 F787_R843del/+ . The Luminex platform was used to compare the cytokine and chemokine profiles of patients' primary keratinocytes to those derived from unrelated healthy donors. The bona fide inflammasome-dependent cytokine IL-1b was the top cytokine upregulated in keratinocyte cultures derived from MSPC and FKLC probands, followed by TNFa, IL-1RA, IL-1a, TGFa, and GM-CSF ( Figure 7A ; p < 0.05, one-tailed t test). We confirmed the significant increase in IL-1b, IL-18, and IL-1a secretion using quantitative ELISA ( Figure 7B ). These results demonstrate that MSPC and FKLC patients' keratinocytes are prone to spontaneous inflammasome activation and cytokine release in culture. We were also able to observe endogenous ASC oligomers by western blot in DSS-crosslinked keratinocyte lysates from MSPC and FKLC patients, but not in keratinocytes derived from healthy donors ( Figure 7C , lanes 1 and 2 versus lanes 3-6). We did not observe increased IL-1b levels in the sera ( Figures 7D and S7A ) from MSPC and FKLC patients. Interestingly, keratinocytes derived from the father of the FKLC-EG-1 proband also displayed ASC oligomer formation, despite the fact that there was no significant induction of IL-1b and IL-18 secretion. We reasoned that the F787_R843del mutation caused only mild inflammasome activation in the heterozygous state, consistent with his subclinical symptoms. In this regard, it is worth noting that an activating gain-of-function mutation in the same region of murine Nlrp1a displayed no phenotypes in the heterozygous state but caused severe autoinflammation when bred to homozygosity (Masters et al., 2012) .
In Vivo Evidence for
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Finally, we validated the upregulation of inflammatory markers S100A8/9 and S100A7/psoriasin in a primary squamo-proliferative skin lesion biopsy from the MPSC proband MSPC-TN-1 IV: 20 (NLRP1 A54T/+ ) ( Figures 7E and S7B ), further demonstrating that MSPC lesions experience a chronic, unresolved inflammatory response as a result of NLRP1 inflammasome activation.
DISCUSSION
In summary, we have resolved the genetic etiology of two skin disorders, MSPC and FKLC. MSPC patients experience recurrent keratoacanthomas (KA) in palmoplantar skin as well as in conjunctival and corneal epithelia and are highly susceptible to malignant squamous cell carcinoma. FKLC shares multiple clinical symptoms with MSPC but displays more severe symptoms such as generalized lichenoid papular lesions on the limbs and the trunk.
Consequences of NLRP1 Gain-and Loss-of-Function Variants
Our results demonstrate that the two diseases are allelic and both result from germline mutations in the inflammasome sensor, NLRP1. While all MSPC cases are caused by heterozygous missense mutations in the PYD of NLRP1, FKLC arises from bi-allelic inheritance of an internal deletion within the highly conserved NLRP1 LRR domain. Functionally, all MSPC and FKLC mutations in NLRP1 are gain of function and lead to increased inflammasome activation. Although the function of endogenous NLRP1 in immune defense is still unclear, it is noteworthy that NLRP1 homologs in other mammals such as elephant, hedgehog, and dolphin have acquired a large number of null mutations such that NLRP1 can be considered to be a pseudo gene in these mammalian species. Importantly, at least five healthy individuals have been found to carry homozygous splice site mutations in NLRP1 (Sulem et al., 2015) . The identification of these possible NLRP1-null healthy individuals suggests that the absence of NLRP1 is likely much less detrimental than gain-of-function mutations.
Proposed Model of Pathogenesis for MSPC and FKLC
We propose that chronic, unresolved keratinocyte-driven inflammation underlies the pathology in MSPC and FKLC ( Figure 7F ). The characteristic recurrent focal lesions in both diseases likely originate from the aberrant activation of NLRP1 inflammasome in select keratinocytes. The ensuing rapid, localized release of IL-1 cytokines likely kick starts a paracrine signaling network involving neighboring keratinocyte and fibroblasts, leading to the secretion of secondary inflammatory cytokines and growth factors, such as TNFa and KGF. This aberrant ''wound-healing''-like response then leads to epidermal hyperplasia and keratoacanthoma formation. As the lesion grows and disrupts the skin barrier, infiltrating immune cells might act to control and restrict the lesion, leading to regression as is observed in MSPC patients. However, the continuous unresolved inflammation over many years could facilitate the acquisition of additional oncogenic mutations and promote malignant transformation toward SCC development ( Figure 7F ).
A Novel Mechanism of PYD-Mediated Inflammasome Regulation
Our biochemical analyses revealed unique biochemical properties of NLRP1. NLRP1 PYD unexpectedly functions as an autoinhibitory domain, unlike the PYDs of other known inflammasome sensors. Thus, despite having both a PYD and a CARD, we propose that NLRP1 be classified functionally as an NOD-, LRR-and CARD-containing (NLRC) protein rather than an NOD-, LRR-, and pyrin domain containing (NLRP) protein. NLRP1 PYD functions non-redundantly with the LRR domain to maintain NLRP1 in an inactive monomeric form. When either domain is mutated as in the case of MSPC and FKLC, this auto-inhibitory mechanism is lost. This results in an increased propensity for NLRP1 to oligomerize. We further demonstrated that the monomer-to-oligomer transition is an obligatory step for NLRP1 inflammasome activation and requires the autoproteolytic cleavage of the FIIND domain. These findings define a new mechanism for inflammasome regulation and provide a conceptual framework for future structural studies.
Inflammasome in Skin Cancer Susceptibility and Skin Inflammatory Diseases
There is mounting evidence from murine studies implicating inflammasome components in epithelial hyperplasia (Drexler et al., 2012; Man et al., 2015; Wilson et al., 2015) . Our study establishes the first link between aberrant inflammasome activation and inherited inflammatory and proliferative skin disorders. This raises the possibility that inflammasome modulation could be used clinically to ameliorate chronic skin inflammatory diseases and decrease the risk for epithelial skin tumor.
NLRP1 is highly polymorphic in the general human population. We speculate that each NLRP1 haplotype is associated with a different propensity for activation, with the MSPC and FKLC mutants representing the extreme end of this spectrum. This hypothesis agrees with previous GWAS studies linking NLRP1 SNPs to generalized vitiligo, Addison's disease, and congenital toxoplasmosis (Cavailles et al., 2014; Jin et al., 2007) . Moreover, the phenotypes of FKLC overlap significantly with several common dermatologic diseases, such as keratosis pilaris and lichen planus, for which mechanistic insights are currently lacking. Therefore, we anticipate that our findings will pave the way for future work to uncover the role of NLRP1 inflammasome in additional human disease states, including inflammatory and autoimmune skin diseases, as well as skin cancer.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Cell Culture All 293T and derivative cell lines were cultured in complete high-glucose DMEM media (Life Technologies) supplemented with 10% FBS. THP-1 cells were cultured in RPMI-1640 media supplemented with 10% FBS. THP-1 differentiation was induced by incubation with 400 ng/ml phorbol myristoyl acetate for 48 hr. Primary keratinocytes and fibroblasts from healthy human skin were obtained from de-identified surplus surgical waste with fully informed consent and obtained with full ethical clearance through the IMB Skin Cell Bank. Primary keratinocytes from MSPC and FKLC patients were isolated from fresh skin punch biopsies and grown on mouse 3T3 feeder cells. Immortalized N/TERT-1 keratinocytes (a gift from Prof. J.G. Rheinwald) were cultured in KSFM media (Life Technologies) supplemented with 300 mM CaCl 2 .
METHOD DETAILS Exome Sequencing of MSPC Families
For MSPC exome sequencing, 1 mg of purified genomic DNA was subjected to exome capture using Illumina TruSeq Exome Enrichment Kit (Illumina). Illumina HiSeq2500 high output mode was used for sequencing as 100 bp paired-end runs at the UCLA Clinical Genomics Centre. Sequence reads were aligned to the human reference genome (Human GRCh37/hg19 build) using Novoalign (v2.07). PCR duplicates were identified by Picard (v1.42) and GATK (Genome Analysis Toolkit) (v1.1) was used to re-align insertions and deletions (INDELs), recalibrate the quality scores, call, filter, recalibrate, and evaluate the variants. SNVs and INDELs across the sequenced protein-coding regions and flanking junctions were annotated using Variant Annotator X (VAX), a customized Ensembl Variant Effect Predictor (Yourshaw et al., 2015) . An average coverage of $85X was achieved across the exome.
Exome Sequencing of FKLC-EG-1
Following informed consent, genomic DNAs from two affected siblings were subjected to whole-exome capture using in-solution hybridization with the SureSelect All Exon 50 Mb Version 4.0 (Agilent) followed by massively parallel sequencing (Illumina HiSeq2000) with 100 bp paired-end reads. The resulting variant calls were filtered with the BCFtools utility (http://samtools.github.io/bcftools/), filtered for a minimum coverage (calls with fewer than four reads filtered) and hard filtered for quality (variants with quality < 20 filtered from further analysis). This high-quality call set was then annotated with respect to the genes, and for consequences on protein sequence and/or splicing with the ANNOVAR tool (http://annovar.openbioinformatics.org/en/latest/). Further annotation was done through further rounds of ANNOVAR annotation against dbSNP135 (http://www.ncbi.nlm.nih.gov/snp), population frequency estimates from the 1000 Genomes project (http://www.1000genomes.org/) and the National Institutes of Health Heart, Lung and Blood Institute Grand Opportunity Exome Sequencing Project (https://esp.gs.washington.edu/drupal/), and $2000 control exomes that have been processed through the same bioinformatics analysis pipeline.
RT-PCR, In Situ Staining, and Immunohistochemistry
Human tissue RNA array was purchased from Clontech. cDNA synthesis was performed with iScript cDNA synthesis kit according to the manufacturer's instructions (Clontech) with 1 ug of purified RNA in 20ul. RT-PCR was performed using 1 ul of 10x diluted cDNA using HotStart Taq polymerase (QIAGEN). Q-PCR was performed in triplicate wells using 1 ul of 10x diluted cDNA using SYBR Green Master Mix (ThermoFisher). The primers are listed in STAR Methods. Control skin sections for immunohistochemistry were obtained from de-identified surplus surgical waste with informed consent. RNAscope (Advanced Cell Diagnostics) staining was performed using 'Brown Kit' using manufacturer-supplied controls (dapB and POLII) and a custom-synthesized probe against human NLRP1. Standard immunohistochemistry protocols were followed for NLRP1 staining using a rabbit polyclonal NLRP1 antibody (Adipogen, AL176). For antigen retrieval, slides were heated in Sodium Citrate Buffer (10 mM Sodium Citrate, 0.05% Tween 20 [pH 6.0]) at 95 C for 20 min. Primary antibodies were diluted in antibody dilution buffer (10% normal goat serum, 1% BSA in PBS) overnight at 4 C. Signals were visualized with the Dako EnVision rabbit-HRP kit (Agilent).
Plasmid Construction
To construct plasmids used for transient transfections, PCR-amplified NLRP1 and NLRP3 cDNA were cloned into pCS2+ vector using standard restriction cloning with ClaI and XhoI sites. Doxycycline inducible NLRP1 and NLRP3 expression plasmids were constructed by InFusion cloning of the respective cDNA fragments into an AgeI-EcoRI linearized pTRIPZ backbone (Clontech). ASC-GFP lentiviral construct was assembled by Infusion Cloning (Clontech) in pCDH-puro (Systems Bio).
Transient Transfection and Stable Lentiviral Overexpression
All lentiviruses were produced in 293T cells by co-transfection of second generation helper plasmids, concentrated using Lenti-X (Clontech) and kept as frozen stock until use. 293T transient transfection experiments were performed using Lipofectamine 2000 (Life Technologies), while all transfection experiments in immortalized keratinocytes were carried out using FugeneHD (Promega) using a '3:1' ratio according to the supplied protocol. Pooled siRNAs against human PYCARD (ASC) were purchased from ThermoFisher and transfected with Lipofectamine RNAiMax (Life Technologies).
DSS Crosslinking
All harvested cell pellets were kept at À80 C till use. For DSS crosslinking, cell pellets from a confluent well in 6 well plate were suspended in 200ul of 1mM DSS in PBS for 15mins at 37 C with constant mixing. Crosslinked pellets were centrifuged at 20,000 RCF for 5 min. Protein complexes were solubilized in 1x Laemmli SDS-PAGE buffer for 10 min at 95 C and centrifuged again at 20,000 RCF for 5 min. The supernatant was used for western blot analysis.
SDS-PAGE, Western Blotting, and ELISA Protein lysate was quantified using the Bradford assay and 20 mg was used per well for SDS-PAGE. Proteins were transferred using TransBlot (Bio-rad) using the 'mixed molecular weight' setting (25V, 7 min). Western blotting was carried out with overnight incubation of primary antibodies diluted in 1xTBS with 1% Tween-20 and 3% non-fat milk at 4 C. All ELISA experiments were performed strictly according to the manufacturers' recommended protocols.
Immunofluorescence 293T-ASC-GFP cells were seeded at $70% confluence on poly-lysine coated coverslips. N/TERT immortalized keratinocytes were seeded on uncoated coverslips. All cells were grown in growth media and allowed to adhere overnight. Coverslips were fixed with 4% paraformaldehyde in 1xPBS and permeablized with 0.5% Triton-X in 1x PBS. All primary antibodies were diluted in PBS with 1% BSA and 0.05% Triton-X. Primary antibody incubation was performed at 4 C overnight with gentle mixing. Secondary antibody incubation was performed for 1-2 hr at room temperature. Coverslips were mounted with DAPI-containing Prolong Gold mounting media (ThermoFisher).
Blue-Native PAGE and 2D-PAGE Blue-Native PAGE was performed using the Novex NativePAGE Bis-Tris gel system (ThermoFisher) according to the manufacturers' instructions with minor modifications. Briefly, 293Ts cells were transfected with various NLRP1 expression plasmids at a ratio of 1ug plasmid per well in a standard 6 well plate using Lipofectamine 2000 reagent (ThermoFisher). Cells were harvested 48 hr post transfection and lysed in Sample Prep buffer containing 1% digitonin, clarified by centrifugation at 20,000 RCF for 10 min and supplemented with Coomassie G-250 to a final concentration of 0.25%. 10ul of protein lysate per well was using for BN-PAGE. Electrophoresis was performed with the 'dark blue' cathode buffer for $1 hr at 150 V constant voltage, followed by the 'light blue' buffer at 250V for $1.5 hr. The proteins were transferred onto a PVDF membrane using a Trans-Blot Turbo system at 25 V for 10 min and detected by standard western blot procedures without the recommended acetic acid fixing step. For 2D PAGE, the entire BN-PAGE gel lane was excised and cut into 8 slices. Each slice was eluted in an elution buffer containing 50 mM Tris-HCl, 150 mM NaCl and 0.1% SDS overnight at room temperature with constant mixing. The supernatant was concentrated the next day using an Amicon Ultra 0.5 mL filter (MWCO = 30 kDa) (Merck Millipore) to 40 ml and supplemented with 10 ml 1x Laemmli buffer.
Luminex Multiplex Cytokine/Chemokine Array Luminex multiplex cytokine and chemokine array was performed according the manufacturer's protocol, using the human cytokine/ chemokine panel I (HCYTMAG-60K-PX41 Merck Millipore). Cytokine levels from different samples were analyzed using 'hierarchical clustering' in Multiple Experiment Viewer (http://www.tm4.org/).
Recombinant Protein Purification and NMR Structural Analysis
Recombinant GB1-PYD WT and its mutants were expressed in E. coli BL21. All recombinant proteins were purified from the soluble fraction to homogeneity by Superdex 75 gel-filtration chromatography (GE healthcare) with an elution buffer containing 50 mM Na 2 HPO 4 , 50mM NaCl, 20 mM DTT at pH 6.5. For NMR studies, U-15 N-labeled proteins were produced by using standard C in Bruker 600 and 700 MHz spectrometers equipped with room-temperature and cryogenic triple-resonance probes.
RNA-Seq
Total RNA samples were processed using the Illumina TruSeq stranded mRNA kit. Prepared libraries were quantified using KAPA qPCR and Agilent Bioanalyzer, and sequenced on the Illumina HiSeq-2000. The reads were processed and mapped using TopHat and CuffLink in the Galaxy suite. Differential gene expression was obtained using CuffDiff.
Phylogenetic Analysis of PYDs
Amino acid sequences of PYDs in the human genomes were downloaded from Prosite and aligned using the Muscle algorithm. Sequence similarity was computed using ClustalW2-Phylogency using the Neighbor-joining clustering method and visualized using Tree-Of-Life (http://itol.embl.de/).
3D Skin Organotypic Co-cultures
Briefly, keeping all solutions on ice, each gel was formed by using 8 parts collagen (rat tail collagen type I (BD biosciences) suspended in acetic acid) mixed with 1 part 10x DMEM and 1 part FBS containing 1 3 105 normal human fibroblasts (NHF). The collagen-NHF mix was then loaded into a cell culture insert (BD Biosciences) and allowed to solidify at 37 C before adding NHF media to the culture. After three days 1 x10 6 normal human primary keratinocytes (NHK) were seeded on-top of the collagen gel, in NHK medium. The next day the cultures were raised to the air-medium interface. After airlift, the gels were then treated either with a mixture of cytokines, to give a final concentration of 10 ng/ml each, or left untreated as a control. The additives were then replaced with medium change every 2-3 days. Organotypic co-cultures were harvested after 7 days and embedded in OCT for cryo-sectioning.
Immunofluorescence Staining of Organotypic Cultures
Frozen sections of 3D organotypic cultures, were exposed to 1:1 methanol:acetone fixation before incubation with 10% goat serum for 20 min, to block non-specific binding. Primary antibodies were then added overnight at 4 C. Primary antibodies include rabbit ki67 (ab15580, Abcam, 1:50), mouse keratin 10 (clone DEC10, Leica, 1:50), involucrin (clone SY5, Abcam, 1:100), S100A7 (clone MAC 387, Dako, 1:50) and S100A9/8 (Psoriasin, NovousBio, 1:50). Secondary antibodies (AlexaFluor 594 goat anti-rabbit or AlexaFluor 488 goat anti-mouse) were then added for 20 min at room temperature. Nuclei were counter stained with DAPI. Coverslips were mounted onto glass slides using Hydromount mounting media (National Diagnostics) before microscopic visualization.
Circular Dichroism Spectroscopy of NLRP1 PYD Domain Circular dichroism (CD) measurements were performed on a Chirascan qCD series spectropolarimeter. Samples were diluted in 50 mM phosphate buffer, 50 mM NaCl, 20 mM DTT (pH 7.4) to a final protein concentration of 0.1 mg/mL. The protein concentration was determined by measuring absorbance at 280 nm. Native CD spectra were recorded over the wavelength range of 200À260 nm in a cuvette with a path length of 0.1 cm at the temperature of 293K. Samples were pre-equilibrated for 15 min prior to running the experiments. The 'blank' signal obtained for the buffer alone was subtracted from the individual protein spectra. Thermal denaturation CD profiles were acquired by monitoring the ellipticity at 222 nm in the range from 293K to 365K using a water bath controlled by a Peltier device. The signal was recorded at 0.1K intervals and 1.5 s of response time. The CD signal was converted to mean residue molar ellipticity as follows. ½q = 10 6 q ½CNl where [C] is the protein concentration, N is the protein residue number and l is the path-length (in cm). Calculated mean residue molar ellipticity is given in deg cm 2 dmol À1 . The CD thermal unfolding data were analyzed using least-squares minimization for the fitting two-state equilibrium unfolding model.
Fluorescence Anisotropy of ASC Filamentation
A fluorescence polarization-based assay was used to measure the reaction kinetics of ASC filament formation. Dylight Fluor 488 was conjugated irreversibly to a single cysteine residue of ASC in an overnight reaction and under denaturing conditions. Chromophorelabeled ASC-PYD was further purified by dialysis and size exclusion chromatography to remove unreacted free dye. ASC filament reconstitution was initiated by rapid mixing to physiological pH conditions. Filament formation is accompanied by a change in the rotational correlation time of the fluorophore covalently attached to monomeric ASC-PYD, which results in changed fluorescence polarization. The fluorescence polarization time course was measured on a Synergy H1 Hybrid microplate reader (Biotek). Data were acquired in 10 s intervals for a total time of 120 min.
QUANTIFICATION AND STATISTICAL ANALYSIS
A custom ImageJ workflow was used for the percentage calculation of ASC-GFP speck-containing cells. Briefly, the total cell number per image was counted in ImageJ using binary intensity thresholding of the DAPI images, a 'watershed' filter followed by the automatic 'particle count' algorithm, with a minimum cut-off radius of 50 pixels. ASC-GFP specks were counted in the same way using the GFP images, except no watershed filter was applied and the minimum radius was set at 10 pixels. For each sample, three fields were chosen at random and at least 100 cells were scored. All bar graphs were calculated based on three independent replicates, except experiments involving primary patient keratinocytes and sera (Figures 7 and S7) , where error bars were calculated from three technical replicates.
The following experiments were performed with the experimented blinded to the sample identity: Luminex cytokine/chemokine array ( Figure 7A ), all image analysis for 293T-ASC-GFP assays, ELISA for primary keratinocytes and patient sera (Figures 7B-7D) . Other experiments were not performed in a blinded fashion.
The p values from all pairwise comparisons were calculated using two-tailed Student's t test, except the Luminex array data, where a one-tailed t test was used ( Figure 7A ). Statistical tests were performed in GraphPad Prism 6 or Microsoft Excel using the TTEST function. Bar graphs were plotted as mean ± SDM and statistical significance was denoted as follows: *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
DATA AND SOFTWARE AVAILABILITY
Data Resources
The accession number for the RNA-seq data reported in this paper is GEO: GSE85791. (Baker et al., 2015) . A) Wild-type NLRP1 is predominantly a monomer. 293T cells transiently transfected with HA-tagged wild-type NLRP1 were lysed in BN-PAGE lysis buffer containing 1% digitonin. 20 mg of lysate was analyzed on Blue Native PAGE along with 1ng of purified rabbit IgG, followed by western blot with a rabbit anti-HA antibody. An HRP-conjugated secondary antibody against all rabbit IgG subtypes was used to visualize NLRP1 and the purified rabbit IgG in the native form. Rabbit IgGs are $150kDa in molecular weight. (B) NLRP1 M77T mutation leads to increased oligomerization by the C-terminal cleavage fragment. 20 mG of 293T lysate expressing wild-type NLRP1 and NLRP1 M77T were fractionated using Blue Native PAGE. After electrophoresis, entire lanes were excised from the gel and cut into 8 equal pieces. Proteins were eluted from each gel fraction in 50mM Tris-HCl, 0.1% SDS, 150mM NaCl at pH 7 at room temperature overnight and concentrated 50-fold. The concentrated proteins were further analyzed along the second dimension by SDS-PAGE. 
